Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® received a Bronze Best in Biz Award
| SAN DIEGO, Dec. 3, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (“the Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® received a Bronze Best in Biz Award for Most Innovative Product of the Year – Consumer for its high-quality hemp-derived cannabidiol (CBD) products. Also, Kannaway® CEO Blake Schroeder received a Bronze Award for Executive of the Year – Small Companies. Since 2011, the Best in Biz Awards has maintained its premier status as the only independent business awards program judged by prominent reporters and editors from top-tier publications from North America and around the world, from The Associated Press to The Wall Street Journal. Entrants have spanned many categories and industries from local companies and start-ups to some of the most recognizable global brands. With more than 700 entries, the ninth annual program attracted a record number of entries from an impressive array of public and private companies of all sizes and spanning all geographic regions and industries in the U.S. and Canada. “I am honored to be recognized by the prestigious Best in Biz Awards as part of Kannaway’s continued growth and success,” said Kannaway® CEO Blake Schroeder. “We’re very proud to be able to offer high-quality hemp-derived products to consumers throughout the U.S. and internationally and hope that these awards will help us raise awareness to the hard work we are doing to control the consistency and safety of our products.” Kannaway®, the first direct-selling company to bring hemp-based CBD products to market in the U.S. and Europe, received this award for Most Innovative Product – Consumer because of its commitment to creating products that consumers can trust. Each product is Triple Lab Tested™ to ensure that they are safe from contaminants and are accurately labeled. Also, Kannaway® was one of the first companies to receive a Certification Seal for its products by top industry group U.S. Hemp Authority. Schroeder, the only winner of the Executive of the Year award in the Small Business category, is one of 40 leaders recognized by the 2019 Best in Biz Awards. The award credits his efforts in growing Kannaway®'s revenue in 2018 nearly 200% over 2017 revenue, spearheading new European operations and expanding the Company’s product offerings. Since joining Kannaway®, Schroeder has grown the Company’s revenue more than 60 times. “These awards help consumers distinguish who the serious and trustworthy businesses and business leaders are,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We are optimistic that being listed among some of the largest, most recognized companies will help us gain consumer confidence and help us make hemp-derived products accessible worldwide.” For a full list of 2019 Best in Biz Awards or to learn more about the award criteria, please visit https://www.bestinbizawards.com/2019-winners/. To learn more about Kannaway, please visit http://www.kannaway.com. About Kannaway® About Medical Marijuana, Inc. To see Medical Marijuana, Inc.'s corporate video, click here. Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop. FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein. FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE LEGAL DISCLOSURE CONTACT: Investor Relations Contact:
SOURCE Medical Marijuana, Inc. | ||
Company Codes: OTC-PINK:MJNA, OTC-QB:MJNA |
View original content:
